Overview

A Study to Evaluate Vitamin B3 Derivative to Treat Mitochondrial Myopathy

Status:
Not yet recruiting
Trial end date:
2025-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effects of Nicotinamide Riboside (NR) supplement in adult-onset symptoms of mitochondrial myopathy.
Phase:
Phase 2
Details
Lead Sponsor:
Eduardo N. Chini
Treatments:
Niacin
Niacinamide
Nicotinic Acids